Wanbury Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2013
2015
2016
2017
2018
Net Income before Extraordinaries
870,924.00
44,786.00
71,464.00
46,050.00
-
Depreciation, Depletion & Amortization
225,892.00
48,042.00
90,524.00
103,155.00
-
Other Funds
640.00
-
121,282.00
-
-
Funds from Operations
221,777.00
60,712.00
182,322.00
104,953.00
217,059.00
Changes in Working Capital
644,691.00
131,250.00
23,636.00
178,735.00
-
Net Operating Cash Flow
422,914.00
191,962.00
205,958.00
283,688.00
-
Capital Expenditures
190,427.00
52,529.00
212,144.00
203,075.00
-
Sale of Fixed Assets & Businesses
1,632.00
-
13.00
56,052.00
-
Purchase/Sale of Investments
17,310.00
2,899.00
8,261.00
6,735.00
-
Net Investing Cash Flow
171,485.00
55,428.00
203,870.00
140,288.00
-
Issuance/Reduction of Debt, Net
224,012.00
83,622.00
169,878.00
109,416.00
-
Net Financing Cash Flow
224,652.00
83,622.00
48,596.00
109,416.00
-
Net Change in Cash
26,777.00
52,912.00
46,508.00
33,984.00
-
Free Cash Flow
232,487.00
139,433.00
6,186.00
82,241.00
-

About Wanbury

View Profile
Address
BSEL Techpark, B-Wing, Sector 30-A
Mumbai Maharashtra 400703
India
Employees -
Website http://www.wanbury.com
Updated 09/14/2018
Wanbury Ltd. engages in the business of pharmaceutical and related activities, including research. The company focuses on orthopedics, gastrointestinal, gynecology and surgery therapeutic segments. The company was founded in 1990 and is headquartered in Mumbai, India.